Background Analysis: US FDA Advisory Committees to Consider Additional Restrictions on the Pediatric Use of Codeine – DEC 10, 2015 (PADAC-DSRM)

The US FDA has scheduled a joint meeting of the Pulmonary-Allergy Drugs Advisory Committee (PADAC) and Drug Safety and Risk Management Advisory Committee (DSRM) for Thursday, December 10, 2015 to discuss the safety of codeine in children 18 years of age and younger.

See the SAC Tracker report